Does the presence of connective tissue disease modify survival in patients with pulmonary fibrosis?

Dec-11

AUTHORS : Dr Vidya Navaratnam, University of Nottingham, Division of Epidemiology and Public Health, Clinical Sciences Building, Nottingham City Hospital, Hucknall Road, Nottingham, NG5 1PB, UK – Email: vidya.navaratnam@nottingham.ac.uk

JOURNAL : Respiratory Medicine

REFERENCE: 105(12):1925-30

DOI : 10.1016/j.rmed.2011.08.015

Does the presence of connective tissue disease modify survival in patients with pulmonary fibrosis?

More publications

COPD Exacerbations Before and During COVID-19 in France, Germany, Italy, the UK and the US

Duration of Invasive Mechanical Ventilation before Veno-Venous ExtraCorporeal Membrane Oxygenation for Covid-19 related Acute Respiratory Distress Syndrome: The experience of a tertiary care center

Use and persistence of single and multiple inhaler triple therapy prescribed for patients with COPD in France: a retrospective study on THIN database (OPTI study)